FDA Approved: ARIXTRA — Supplemental Application (Mylan Institutional LLC)

View source ↗

Summary

The FDA approved a supplemental application for ARIXTRA (fondaparinux sodium) filed by Mylan Institutional LLC. The approval updates the existing ARIXTRA labeli…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Deep Vein Thrombosis
• Pulmonary Embolism
• Venous Thromboembolism

Drugs mentioned

• ARIXTRA (fondaparinux sodium)

Snippet

SUPPL AP for ARIXTRA (FONDAPARINUX SODIUM)